Ixazomib citrate EtOH
Ixazomib citrate (MLN9708) is an orally bioavailable prodrug that hydrolyzes to the active proteasome inhibitor ixazomib (MLN2238) . This second-generation inhibitor demonstrates preclinical and clinical antimyeloma activity, with improved pharmacokinetic and antitumor profiles compared to bortezomib in both in vitro and in vivo studies.
Product Specifications
CAS Number
2026591-78-4
Field of Research
Pharmacology & Drug Discovery
Smiles
CCO.CC (C) C[C@H] (NC (=O) CNC (=O) c1cc (Cl) ccc1Cl) B1OC (=O) C (CC (O) =O) (CC (O) =O) O1
Molecular Formula
C22H29BCl2N2O10
Molecular Weight
563.188
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K5006304 1.0 µg DNA
Ghitm sgRNA CRISPR Lentivector (Mouse) (Target 3)
Sign In for Pricing
View Details 
LV762006 1.0 µg DNA
GAPDHP51 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)
Sign In for Pricing
View Details A05883-2-Fluoro488 100 µg/Vial
Anti-RAB31 Antibody Picoband® Fluoro488 Conjugated
Sign In for Pricing
View Details 
K0225103 1.0 µg DNA
C2orf56 sgRNA CRISPR Lentivector (Human) (Target 2)
Sign In for Pricing
View Details bs-3310R-HRP 100 µL
Phospho-NPM (Thr199) Polyclonal Antibody, HRP Conjugated
Sign In for Pricing
View Details